Cambridge Investment Research Advisors’s Eventide US Market ETF ESUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.65M Buy
118,985
+6,104
+5% +$176K 0.01% 1235
2026
Q1
$2.96M Buy
112,881
+14,878
+15% +$405K 0.01% 1291
2025
Q4
$2.64M Buy
98,003
+28,744
+42% +$781K 0.01% 1317
2025
Q3
$1.88M Buy
69,259
+27,386
+65% +$729K 0.01% 1551
2025
Q2
$1.09M Buy
41,873
+24,587
+142% +$595K ﹤0.01% 1880
2025
Q1
$408K Buy
+17,286
New +$426K ﹤0.01% 2624

Other funds holding ESUM

Cambridge Investment Research Advisors's ESUM Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Eventide US Market ETF (ESUM) stake by 5.4% in Q2 2026, buying an estimated $176K and bringing the position to 118,985 shares worth $3.65M. The position accounts for 0.01% of the portfolio, ranked #1235.

Cambridge Investment Research Advisors first reported a position in ESUM in Q1 2025 and has held it in 6 quarters since. 39 funds tracked by Wall St. Rank hold ESUM as of Q2 2026.

  • Cambridge Investment Research Advisors held 118,985 shares of Eventide US Market ETF worth $3.65M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 6,104 Eventide US Market ETF shares in Q2 2026, an estimated $176K.
  • Eventide US Market ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1235 holding.
  • Cambridge Investment Research Advisors first reported a position in Eventide US Market ETF in Q1 2025 and has held it in 6 quarters since.
  • 39 funds tracked by Wall St. Rank held Eventide US Market ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.